Last €2.41 EUR
Change Today -0.026 / -1.07%
Volume 0.0
IM3 On Other Exchanges
Symbol
Exchange
NASDAQ GM
Frankfurt
As of 2:08 AM 08/29/14 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for immunomedics inc (IM3)

Year over year, Immunomedics Inc. has been seen their bottom line shrink from a loss of $11.4M USD to an even larger loss of $35.4M USD. despite revenues that grew from $5.0M USD to $9.0M USD over the same time period.
Currency in
Millions of US Dollars
As of:Jun 30
2011
Restated
Jun 30
2012
Restated
Jun 30
2013
Restated
Jun 30
2014
4 Year
Trend
Revenues14.732.75.09.0
TOTAL REVENUES14.732.75.09.0
Cost of Goods Sold25.024.728.81.5
GROSS PROFIT-10.28.1-23.87.5
Selling General & Admin Expenses, Total7.96.67.09.4
R&D Expenses------33.7
OTHER OPERATING EXPENSES, TOTAL7.96.67.043.1
OPERATING INCOME-18.21.4-30.8-35.6
Interest and Investment Income0.10.00.0--
NET INTEREST EXPENSE0.10.00.0--
Currency Exchange Gains (Loss)0.00.00.00.0
Other Non-Operating Income (Expenses)------0.1
EBT, EXCLUDING UNUSUAL ITEMS-18.01.5-30.8-35.5
Gain (Loss) on Sale of Investments0.6------
Other Unusual Items, Total3.2--19.4--
Insurance Settlements0.3--2.6--
Other Unusual Items2.9--16.7--
EBT, INCLUDING UNUSUAL ITEMS-14.31.5-11.4-35.5
Income Tax Expense0.10.20.00.0
Minority Interest in Earnings0.20.10.10.1
Earnings from Continuing Operations-14.41.3-11.5-35.5
NET INCOME-14.21.4-11.4-35.4
NET INCOME TO COMMON INCLUDING EXTRA ITEMS-14.21.4-11.4-35.4
NET INCOME TO COMMON EXCLUDING EXTRA ITEMS-14.21.4-11.4-35.4
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
IM3:GR €2.41 EUR -0.026

IM3 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for IM3.
View Industry Companies
 

Industry Analysis

IM3

Industry Average

Valuation IM3 Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 32.0x
Price/Book 7.4x
Price/Cash Flow NM Not Meaningful
TEV/Sales 28.9x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact IMMUNOMEDICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.